I-RapidASCVD ilinganisa ngokunembile iminyaka eyi-10 ye-ASCVD (isifo se-atherosulinotic senhliziyo). I-interface yomsebenzisi yenziwe yaba ngejubane ukuze odokotela abaxakekile bakwazi ukubala izilinganiso ze-ASCVD zeziguli inani elisheshayo lesikhathi - ngokuvamile phakathi kwemizuzwana eyi-10-15.
Ingozi ye-ASCVD kungenzeka ukuthi isiguli sibe nomcimbi wokuqala (wokuqala) wesifo senhliziyo (njenge-myocardial infarction), isifo se-cerebrovascular (efana nesifo sohlangothi), nesifo se-aripial aripial. Lokhu kulinganisela akulungile ukuthi kusetshenziswe ezigulini esezivele zinesinye salezi zigameko zenhliziyo.
I-RapidASCVD ihlolwe kabanzi ukuthola ukunemba nge-equoled cohort equations (2013 ACC / AHA Guideline ekuHlolweni kwe-Cardiovascular Risk. Doi: 10.1161 / 01.cir.0000437741.48606.98), ethathwe kokuhluka okulandelayo:
• Ubudala
• I-cholesterol ephelele
• I-cholesterol ye-HDL
• Umfutho wegazi weSystolic
• Ucansi
• Ubuhlanga
• Ubukhona bokwelashwa kwe-antihypertensive
• Umlando wesifo sikashukela mellitus
• Isimo sokubhema samanje
Ukulinganiselwa kwengozi kuhambelana nemihlahlandlela yonyaka ka-2019 ACC / AHA ekuvinjelweni kokuyisisekelo kwesifo sezinhliziyo (doi: 10.1161 / CIR.0000000000000678), sivuma ukuthi ziningi ezinye zezici zobungozi bezinhliziyo ezikhona ezingabalwa ekubalweni kwengozi kwe-ASCVD. Leli thuluzi lomtholampilo lenzelwe ukuthi lisetshenziswe ngokubambisana nesahlulelo somtholampilo esinengqondo.
Kubuyekezwe ngo-
Aga 23, 2023